Some of the major participants in the antidiabetics market share include Novo Nordisk, AstraZeneca, Bayer Corporation, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Halozyme Therapeutics, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Oramed Pharmaceuticals Inc., Pfizer, Sanofi and Takeda Pharmaceutical.